Alpine Naturaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 04-07-2024
- Paid Up Capital ₹ 0.15 M
as on 04-07-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -88.73%
(FY 2016)
- Profit -6900.51%
(FY 2016)
- Ebitda 10.42%
(FY 2016)
- Net Worth -38.86%
(FY 2016)
- Total Assets -1.52%
(FY 2016)
About Alpine Naturaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Chetan Bhasin and Brij Bhasin serve as directors at the Company.
- CIN/LLPIN
U21022DL2003PTC119831
- Company No.
119831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alpine Naturaceuticals Private Limited offer?
Alpine Naturaceuticals Private Limited offers a wide range of products and services, including Shock Absorber, Piston & Crankshaft Assemblies, Piston Rings, Bolts, Metal Bolts, Detergent, Liquid Detergent, Automotive Components, Automobile Fittings & Components, Surface Cleaner.
Who are the key members and board of directors at Alpine Naturaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Bhasin  | Director | 12-Dec-2021 | Current |
| Brij Bhasin | Director | 12-Dec-2021 | Current |
Financial Performance of Alpine Naturaceuticals.
Alpine Naturaceuticals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 88.73% decrease. The company also saw a substantial fall in profitability, with a 6900.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpine Naturaceuticals?
In 2015, Alpine Naturaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Komfort Life Care Private LimitedActive 17 years 1 monthChetan Bhasin and Brij Bhasin are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alpine Naturaceuticals?
Unlock and access historical data on people associated with Alpine Naturaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpine Naturaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpine Naturaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
